Alexandra Balcom, Chief Financial Officer at Nuvalent, Inc. (NUVL), sold 20,000 shares at $96.25 ($1.9M) on 2024-11-29, disclosed to the SEC on 2024-12-03.
Scheduled sale ($1.9M) by Chief Financial Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $95.69 | 8,142 | $779K | 40.7% |
| 2 | $95.69 | 8,142 | $779K | 40.7% |
| 3 | $96.25 | 1,858 | $179K | 9.3% |
| 4 | $96.25 | 1,858 | $179K | 9.3% |
| Total | $95.79 avg | 20,000 | $1.9M | 100% |
| Filing → |
| NUVL | SELL | 2026-05-05 | $1.1M | — | Filing → |
| NUVL | SELL | 2026-04-03 | $1.2M | — | Filing → |
| NUVL | SELL | 2026-03-26 | $2.5M | — | Filing → |